Cipla plans units for insulin, intravenous drugs and anti-cancer medicinesIllustrative image – not actual.

Cipla, the pharmaceutical company plans to set up new units to manufacture insulin, intravenous drugs and anti-cancer medicines in Goa. 

 

The company plans to invest about Rs.50 crore ($10.2 million) on these projects. Funds for research and development projects are expected to be generated from operating cash and from small bonds.

← All latest storiesBack to top →